Arginine Methyltransferase PRMT7 Deregulates Expression of RUNX1 Target Genes in T-Cell Acute Lymphoblastic Leukemia
T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive hematological malignancy with no well-established prognostic biomarkers. We examined the expression of protein arginine methyltransferases across hematological malignancies and discovered high levels of PRMT7 mRNA in T-ALL, particularly in...
Main Authors: | Haapaniemi, P. (Author), Heinäniemi, M. (Author), Hyvärinen, N. (Author), Kauko, O. (Author), Laukkanen, S. (Author), Lohi, O. (Author), Mäkinen, A. (Author), Nikkilä, A. (Author), Oksa, L. (Author), Rokka, A. (Author), Seki, M. (Author), Takita, J. (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI
2022
|
Subjects: | |
Online Access: | View Fulltext in Publisher |
Similar Items
-
The arginine methyltransferase PRMT5 and PRMT1 distinctly regulate the degradation of anti-apoptotic protein CFLARL in human lung cancer cells
by: Mingyue Li, et al.
Published: (2019-02-01) -
Structure and Function of Protein Arginine Methyltransferase PRMT7
by: Levon Halabelian, et al.
Published: (2021-07-01) -
Arginine Methyltransferase PRMT1 Regulates p53 Activity in Breast Cancer
by: Li-Ming Liu, et al.
Published: (2021-08-01) -
Investigation of the Oxidation/Reduction of PRMT1, Substrate Interactions with PRMT1, and the Role of Argining Methylation in RNA Surveillance
by: Nitzel, Damon V.
Published: (2013) -
PRMT5 function and targeting in cancer
by: Hyungsoo Kim, et al.
Published: (2020-07-01)